Carna Biosciences (TSE:4572) Treasury Stock: 円-0.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4572 Carna Biosciences Inc TSE:4572
38 GF Score
Price 円306.00
GF Value 円185.38
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Treasury Stock?

Carna Biosciences TSE:4572 38 Treasury Stock is 円-0.2 Mil as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 38/100 and a GF Value™ of 円185.38 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Carna Biosciences's treasury stock for the quarter that ended in Dec. 2025 was 円-0.2 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Carna Biosciences Treasury Stock Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Treasury Stock Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.22 -0.22 -0.22 -0.23

Carna Biosciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.22 -0.22 -0.23 -0.23
TSE:4572
38GF Score
Carna Biosciences Inc TSE:4572
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of 円-0.2 Mil mean?
Carna Biosciences (TSE:4572) has a Treasury Stock of 円-0.2 Mil as of Dec. 2025. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Carna Biosciences and its competitors.
Is Carna Biosciences' Treasury Stock too high?
Carna Biosciences' current Treasury Stock is 円-0.2 Mil. Overall, Carna Biosciences has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Treasury Stock compare to VRTX and REGN?
Carna Biosciences' Treasury Stock of 円-0.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Carna Biosciences and its competitors. Carna Biosciences's current Treasury Stock is 円-0.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円185.38, compared to a current price of 円306.00 — trading 65.1% above its estimated fair value. The current Treasury Stock is 円-0.2 Mil. Carna Biosciences' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Treasury Stock is 円-0.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円306.00 is trading 65.1% above its estimated GF Value™ of 円185.38. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Treasury Stock: 円-0.2 Mil
  • GF Value™: 円185.38 vs. price of 円306.00 (65.1% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
38GF Score

Get the complete analysis for TSE:4572

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円306.00
Price
円185.38
GF Value